Captura Biopharma
PrivateLast Round
Corporate Funding
Aug 18, 2021
Est. Valuation
$60M
Company Overview
Captura Biopharma operates in Healthcare & Life Sciences and is based in Little Rock, Arkansas. It was founded in 2019.
Captura Biopharma is a biotechnology company that develops oral chelating agents for the treatment of internal transuranic radionuclide contamination and heavy metal poisoning.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Defense Tech
Business Model
B2G
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Captura Biopharma Comparables
Compare Captura Biopharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HOPO Therapeutics | 90% | |
| Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG | 77% | |
| EmeraMed Limited | 77% |
For institutional investors. Book with your work email.
Captura Biopharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Aug 18, 2021 | ||||
| VC Round | Apr 14, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Captura Biopharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Global Emerging Markets | Corporate Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors grew 69% MoM.
- May 11, 2026
Monthly visitors increased 42% MoM.
For institutional investors. Book with your work email.
Captura Biopharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Captura Biopharma's valuation, stock price, and market status.
Is Captura Biopharma a public or private company?
Captura Biopharma is a private company.
What is the current stock price of Captura Biopharma?
Captura Biopharma is a private company, so its shares have no public market price. Caplight tracks Captura Biopharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Captura Biopharma worth (valuation)?
Captura Biopharma's valuation is estimated at $60.0M based on funding round data.
Can I buy Captura Biopharma stock?
Captura Biopharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Captura Biopharma's last funding round?
Captura Biopharma's most recent funding round was Corporate Funding on August 18, 2021.
Who are the main investors in Captura Biopharma?
Key investors in Captura Biopharma include Global Emerging Markets.
Will Captura Biopharma IPO soon?
No public IPO plans have been announced for Captura Biopharma.
How can I track Captura Biopharma secondary market activity?
Caplight tracks bids, offers, and trades in Captura Biopharma's shares on secondary markets.